Drawing for LUXERONA

USPTO serial 98950826

LUXERONA

Reviewed by CopyMark Law Group

Status 622
Filing date
—
Status date
Registration date
—
Examiner
—
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LUXERONA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Antifungal preparations; Aromatherapy oils, other than essential oils, for {specify use, e.g., treating headaches, relieving stress, curing insomnia, etc.} Aromatherapy oils, other than essential oils, for {specified purposes, such as headache treatment, stress relief, insomnia treatment, etc.}; Dental restoration compounds; Dietary food supplements; Medical preparations for slimming purposes; Medicated cosmetics; Medicated soap; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical products for the treatment of bone diseasesACTIVENov 18, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 9, 2025NOTICE OF INCOMPLETE APPLICATION – EMAILED—
May 8, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 4, 2025CRAFAMENDMENT CORRESPONDENCE ENTERED—
Jan 10, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance